On April 6, 2017, the FDA approved marketing of 23andMe Personal Genome Service Genetic Health Risk tests for 10 diseases or conditions.(FDA Press Release 4-6-17) No prescription or physician needed. These are the first direct-to-consumer tests authorized by the FDA that provide information on an individual’s genetic predisposition to certain medical conditions. Among them, hereditary… Continue reading Direct to consumer thrombophilia testing approved–a good thing?
Today is International Women's Day. One way to honor women is to share life-saving knowledge. So let's talk about venous blood clots because far too many women do not realize they are uniquely at risk for developing this common, potentially life-threatening condition. What is it? Venous thromboembolism (VTE) is a blood clot which forms in… Continue reading Women and Venous Blood Clots: Life saving information on International Women’s Day
One Presidential candidate has a history of venous thromboembolims (VTE). How relevant is that to the campaign and have past Presidents had this condition?
It's the most common, deadly preventable condition which is totally ignored.
I want to like Hillary Clinton. I do. I'd love to see a female president one day. It's just that every time I see and hear the Hillary Clinton campaign slogan “Fighting for Us”, I can’t help but think of the one population Clinton is not fighting for: her fellow patients at risk for venous… Continue reading Fighting for Blood Clot Patients?
How the #1 cause of hospital patient death & #1 cause of maternal death in the US gets $0 funding in the federal budget.
The public and policy makers only know about the public health threats that are included in official statistical reports. Surprisingly, the third leading cause of death in the United States is currently excluded from CDC reports to Congress. Why that matters.